SC to hear PIL seeking direction to govt for ban on unregulated medical devices

Image
ANI General News
Last Updated : Feb 12 2020 | 2:35 PM IST

The Supreme Court will on February 14 hear the PIL (Public Interest Litigation) filed by a doctor, asking for directions to the Central government in connection with an immediate ban on unregulated medical devices which are being sold on-line in open market.

A bench of the apex court, headed by Justice N V Ramana will hear the petition filed by Dr Rohit Jain through his lawyer, Shashank Deo Sudhi on Friday.

Jain had moved the top court, seeking a direction to the government for an immediate ban on the online or offline sale of all names of glucometers/in vitro diagnostic medical devices.

The petition, a copy of which is available with ANI, stated that there are various unregulated medical diagnostic devices, which are easily available in the open market and can be easily purchased by any unqualified, unauthorised and or unlicensed persons.

It further stated that these medical devices are vulnerable to the lives of the common people as there is no regulation enforced on part of the operation of these medical devices.

"It is the need of the hour to formulate a comprehensive guideline to regulate the medical devices being used for generating a clinical report to ascertain its authenticity for proper and accurate treatment," the plea said.

It claimed the government has become completely insensitive to the enormity of the problem being faced by the common people, who are not getting proper medical treatment.

"Ordinary people are forced to go to the illegal and unauthorisedly running diagnostic laboratories which are producing lab report with help of uncalibrated testing equipment," the petition added.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 12 2020 | 2:17 PM IST

Next Story